VentriJect manufactures the Seismofit® System, a certified medical device that utilizes seismocardiography and AI algorithms to accurately estimate VO₂max in under three minutes without requiring physical exertion. This technology addresses the challenge of assessing cardiorespiratory fitness efficiently, providing a reliable health indicator linked to overall mortality risk.
Funding
$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of assessing cardiorespiratory fitness (CRF) and VO₂max often require physical exertion and specialized equipment, making them difficult to administer in certain populations or settings. These traditional tests can be time-consuming, require trained personnel, and may not be suitable for individuals with physical limitations. This creates a need for a more accessible and efficient way to evaluate CRF.
Solution
VentriJect offers the Seismofit® System, a certified medical device that accurately estimates VO₂max in under three minutes without requiring any physical exercise. The system utilizes seismocardiography to capture and analyze mechanical vibrations generated by the heart, which are then processed using proprietary AI algorithms. This non-invasive approach provides a rapid and reliable assessment of cardiorespiratory fitness, a key indicator of overall health and a predictor of mortality risk. The Seismofit® System aims to transform heartbeats into actionable fitness and health insights, offering a compact and portable solution for VO₂max estimation.
Target Audience
The primary users are health professionals, sports medicine experts, and organizations focused on health promotion and preventative care, who need a fast, precise, and uncomplicated way to measure VO₂max.
Features
- Non-invasive VO₂max estimation in under 3 minutes
- Employs seismocardiography to analyze heart vibrations
- Utilizes AI algorithms for accurate VO₂max estimation
- Compact and portable sensor design (3 cm x 5 cm x 1.5 cm, 25g)
- Certified medical device (CE-marked class 1)
- Provides a reliable health indicator linked to overall mortality risk